Dynavax Technologies Corp (DVAX)
12.93
+0.91
(+7.57%)
USD |
NASDAQ |
Nov 08, 15:55
Dynavax Technologies Revenue (TTM): 249.70M for June 30, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| June 30, 2024 | 249.70M |
| March 31, 2024 | 236.15M |
| December 31, 2023 | 232.28M |
| September 30, 2023 | 361.18M |
| June 30, 2023 | 459.40M |
| March 31, 2023 | 655.62M |
| December 31, 2022 | 722.68M |
| September 30, 2022 | 733.26M |
| June 30, 2022 | 673.80M |
| March 31, 2022 | 470.10M |
| December 31, 2021 | 439.44M |
| September 30, 2021 | 263.92M |
| June 30, 2021 | 169.07M |
| March 31, 2021 | 118.97M |
| December 31, 2020 | 46.55M |
| September 30, 2020 | 37.57M |
| June 30, 2020 | 34.73M |
| March 31, 2020 | 40.36M |
| December 31, 2019 | 35.22M |
| September 30, 2019 | 29.97M |
| June 30, 2019 | 20.85M |
| March 31, 2019 | 13.81M |
| December 31, 2018 | 8.198M |
| September 30, 2018 | 2.901M |
| June 30, 2018 | 1.493M |
| Date | Value |
|---|---|
| March 31, 2018 | 0.344M |
| December 31, 2017 | 0.327M |
| September 30, 2017 | 7.598M |
| June 30, 2017 | 7.707M |
| March 31, 2017 | 10.25M |
| December 31, 2016 | 11.04M |
| September 30, 2016 | 4.436M |
| June 30, 2016 | 5.462M |
| March 31, 2016 | 4.365M |
| December 31, 2015 | 4.05M |
| September 30, 2015 | 5.642M |
| June 30, 2015 | 6.663M |
| March 31, 2015 | 8.161M |
| December 31, 2014 | 11.03M |
| September 30, 2014 | 6.464M |
| June 30, 2014 | 7.182M |
| March 31, 2014 | 7.526M |
| December 31, 2013 | 6.113M |
| September 30, 2013 | 6.271M |
| June 30, 2013 | 6.218M |
| March 31, 2013 | 5.51M |
| December 31, 2012 | 5.775M |
| September 30, 2012 | 19.34M |
| June 30, 2012 | 17.64M |
| March 31, 2012 | 22.22M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
34.73M
Minimum
Jun 2020
733.26M
Maximum
Sep 2022
314.74M
Average
249.70M
Median
Jun 2024
Revenue (TTM) Benchmarks
| Biogen Inc | 9.608B |
| Repligen Corp | 602.35M |
| West Pharmaceutical Services Inc | 2.876B |
| XOMA Royalty Corp | 9.807M |
| Xencor Inc | 85.16M |